01.12.2008 | Research Articles
A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer
Erschienen in: Clinical and Translational Oncology | Ausgabe 12/2008
Einloggen, um Zugang zu erhalten